Real-World Data

Analysing the impact of the FreeStyle Libre system on the lives of real users

A FreeStyle Libre System Healthcare Professional and a FreeStyle Libre System user talking and smiling. A FreeStyle Libre System Healthcare Professional and a FreeStyle Libre System user talking and smiling. A FreeStyle Libre System Healthcare Professional and a FreeStyle Libre System user talking and smiling.

Outcomes for people with diabetes

The FreeStyle Libre system is making a real impact on outcomes for people with diabetes.

Icon showing an increase in Time in Range Icon showing an increase in Time in Range

Increases Time in Range1

Icon showing an quality of life increase Icon showing an quality of life increase

Improves quality of life2

Icon for reduced hypoglycaemia Icon for reduced hypoglycaemia

Reduces hypoglycaemia1,3

Icon for decreasing hba1c Icon for decreasing hba1c

Decreases HbA1c4

Learn more about the FreeStyle Libre system in our Educational Modules

Diagram showing: 4 years of data, over 4 million sensors, 4.8 billion glucose readings, 12 scans per day. Diagram showing: 4 years of data, over 4 million sensors, 4.8 billion glucose readings, 12 scans per day.

Real-World Data

More frequent use of the FreeStyle Libre system increases Time in Range5

Comparing two groups from lowest to highest scan rate8, patients who scanned more frequently using the FreeStyle Libre system spent 43% more Time In Range.

5.8 million

FreeStyle Libre sensors

1.71 billion

hours of glucose readings

43%

more Time In Range

(3.9-10.0 mmol/L) from 11.7 to 16.8 hours per day5 (p<0.001)

Frequent use of the FreeStyle Libre system also resulted in patients spending 26% less Time Below Range (<3.0 mmol/L)5

The FreeStyle Libre system is clinically proven to significantly reduce hypoglycaemia in T1D1 and T2D3 patients

Increased testing frequency is sustained over time with the FreeStyle Libre system.9

Impact Study1: T1D Patients

Hypoglycaemia is defined as <3.9 mmol/L.

Impact Study showing how the FreeStyle Libre system positively affects people with type 1 diabetes Impact Study showing how the FreeStyle Libre system positively affects people with type 1 diabetes

Replace Study3: T2D Patients

Impact Study showing how the FreeStyle Libre system positively affects people with type 1 diabetes Impact Study showing how the FreeStyle Libre system positively affects people with type 1 diabetes
Get started with the FreeStyle Academy Get started with the FreeStyle Academy

Get started today

Learn more about the FreeStyle Libre Portfolio and its benefits for your patients with our FreeStyle Academy

Clinical Evidence

Clinical benefits for a broad range of T1D and T2D patients.
 

Training Resources

Explore our training resources to help you to help your patients understand Time in Range better.
 

Educational Modules

Learn more about Time in Range and the FreeStyle Libre system through our Healthcare Professional education modules.


Webinars

We offer various on-demand webinars for Healthcare Professionals including understanding Time in Range.


Webcast Series

Learn more about Time in Range in our CME accredited three-module webcast series.

References & Disclaimers

Images are for illustrative purposes only. Not real patient, data or healthcare professional.

1. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.

2. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019. https://doi:10.1136/bmjdrc-2019-000809.

3. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1): 55-73.

4. Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42(7):1178-1184. 2020;43(2):389-397.

5. Lang J, Jangam S, Dunn T, Hayter G. Expanded real-world use reaffirms strong correlation between scanning frequency of flash glucose monitoring and glucose control [Poster 972]. Diabetes. 2019;68(suppl 1). https://doi.org/10.2337/db19-972-P.

6. Deshmukh H, et al. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit. Diabetes Care 2020;43:2153–2160.

7. From baseline 67.2 mmol/mol HbA1c across the entire study population.

8. Comparing 2 groups from lowest to highest scan rate (3.6 and 39.5 scans/day).

9. Jangam S, Dunn T, Xu Y, Hayter G, Ajjan R. Flash glucose monitoring improves glycemia in higher-risk patients: a longitudinal, observational study under real-life settings. BMJOpen Diab Res Care 2019;7:e000611. DOl:10.1136/bmjdrc-2018-000611.

Loading...